Supernus Pharmaceuticals Inc
NASDAQ:SUPN

Watchlist Manager
Supernus Pharmaceuticals Inc Logo
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Watchlist
Price: 35.6 USD 0.03% Market Closed
Market Cap: 2B USD
Have any thoughts about
Supernus Pharmaceuticals Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Supernus Pharmaceuticals Inc

Current Assets 640m
Cash & Short-Term Investments 403.2m
Receivables 145.4m
Other Current Assets 91.4m
Non-Current Assets 702.7m
PP&E 38m
Intangibles 657.2m
Other Non-Current Assets 7.6m
Current Liabilities 291.5m
Accounts Payable 6.4m
Accrued Liabilities 238.5m
Other Current Liabilities 46.6m
Non-Current Liabilities 44m
Other Non-Current Liabilities 44m

Balance Sheet
Supernus Pharmaceuticals Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
36
34
66
100
192
181
289
203
93
75
Cash Equivalents
36
34
66
100
192
181
289
203
93
75
Short-Term Investments
38
29
24
40
164
166
134
136
368
180
Total Receivables
17
26
42
66
103
87
141
149
166
144
Accounts Receivables
17
26
42
66
103
87
141
149
166
144
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
13
13
17
16
26
27
48
86
92
77
Other Current Assets
4
5
3
7
9
12
19
27
16
17
Total Current Assets
109
106
151
229
494
473
630
602
734
493
PP&E Net
2
4
4
5
4
38
58
52
44
43
PP&E Gross
2
4
4
5
4
38
58
52
44
43
Accumulated Depreciation
6
7
8
9
11
13
17
17
13
15
Intangible Assets
5
1
17
36
31
25
364
785
703
600
Goodwill
0
0
0
0
0
0
78
118
117
117
Long-Term Investments
20
55
75
134
419
592
350
119
94
17
Other Long-Term Assets
0
23
62
21
30
33
23
14
11
9
Other Assets
0
0
0
0
0
0
78
118
117
117
Total Assets
137
N/A
189
+38%
310
+64%
425
+37%
978
+130%
1 160
+19%
1 504
+30%
1 689
+12%
1 703
+1%
1 278
-25%
Liabilities
Accounts Payable
2
4
8
7
3
10
16
9
11
2
Accrued Liabilities
26
52
69
96
144
145
189
241
238
232
Short-Term Debt
0
0
0
0
0
0
0
0
402
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
4
0
0
0
Other Current Liabilities
0
1
3
21
15
6
36
65
38
56
Total Current Liabilities
28
57
81
123
161
161
245
315
688
290
Long-Term Debt
26
7
4
0
330
345
382
379
0
0
Deferred Income Tax
0
0
0
0
0
0
35
85
50
25
Other Liabilities
42
37
33
34
34
59
97
93
79
41
Total Liabilities
96
N/A
101
+5%
118
+17%
157
+33%
525
+234%
565
+8%
759
+34%
873
+15%
816
-7%
356
-56%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
190
176
84
27
87
200
327
380
481
483
Additional Paid In Capital
230
264
276
295
370
388
409
434
408
439
Other Equity
0
1
0
1
3
7
9
2
3
1
Total Equity
41
N/A
88
+116%
192
+118%
268
+39%
453
+69%
595
+31%
745
+25%
816
+10%
886
+9%
922
+4%
Total Liabilities & Equity
137
N/A
189
+38%
310
+64%
425
+37%
978
+130%
1 160
+19%
1 504
+30%
1 689
+12%
1 703
+1%
1 278
-25%
Shares Outstanding
Common Shares Outstanding
43
49
50
51
52
53
53
53
54
55

See Also

Discover More